Adam Levitt is a partner at DiCello Levitt LLP and is one of the nation’s leading advocates for plaintiffs in complex, multidistrict, class action, public client, mass tort, and commercial litigation. Drawing on his extensive experience pursuing and obtaining justice for those who have been wronged by powerful defendants, he co-founded DiCello Levitt to create a top complex issues and trial firm, built on excellence, trust, and respect—where every team member’s voice and talents are valued.
In his decades-long career, Adam has scored numerous significant and precedent-setting victories, delivering more than $25 billion in recoveries to clients in biotechnology, financial services, securities, insurance coverage, consumer protection, automotive defects, agricultural products, and antitrust disputes. His reputation for innovatively taking on tough cases has led to his appointment to leadership positions in many historic and headline-grabbing litigations.
Adam served as co-lead counsel in three of the largest biotechnology class actions in U.S. history, helping recover more than $1.7 billion on behalf of plaintiffs and creating a game- changing economic model to measure crop contamination damages that set the modern industry standard. He was also retained by multiple State Attorneys General to hold some of the world’s largest chemical companies accountable for widespread environmental contamination from their “forever chemicals” known as PFAS (per- and polyfluoroalkyl substances). Additionally, the City of Baltimore retained Adam to address the catastrophic impact of the Francis Scott Key Bridge collapse, one of the largest maritime disasters in U.S. history.
